NCT06337110View on ClinicalTrials.gov

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

May 11, 2024

Study Completion Date

May 11, 2024

Conditions
Healthy Participants
Interventions
DRUG

Lu AF28996

Oral solution containing radiolabelled \[14C\]-Lu AF28996.

Trial Locations (1)

LS11 9EH

Fortrea Clinical Research Unit Ltd, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT06337110 - A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men | Biotech Hunter | Biotech Hunter